PRJNA714090
Probiotic normalization of systemic inflammation in siblings of Type 1 diabetes patients
A 6-week, single-arm, open-label trial was conducted to investigate whether daily multi-strain probiotic (Bifidobacteria, Lactobacillus, and Streptococcus) supplementation could reduce the familial inflammatory state in 25 unaffected siblings of diabetes patients